BiotechTube
Home/Equillium/Krishna Polu, M.D.
KP

Krishna Polu, M.D.

Former Chief Medical Officer

Equillium

Therapeutic Areas

Autoimmune DiseasesInflammatory Disorders

Equillium Pipeline

DrugIndicationPhase
Itolizumab (EQ001)Acute Graft-Versus-Host Disease (aGVHD)Phase 1b
EQ504Inflammatory & Autoimmune Disorders (e.g., Asthma)Preclinical / Early Clinical